Astellas Pharma Inc. (ADR)

General ticker "ALPMY" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $18.3B (TTM average)

Astellas Pharma Inc. (ADR) follows the US Stock Market performance with the rate: 46.2%.

Estimated limits based on current volatility of 0.6%: low 13.04$, high 13.20$

Factors to consider:

  • Company pays dividends (semi-annually): last record date 2025-09-30, amount 0.23$ (Y3.48%)

Similar symbols

Short-term ALPMY quotes

Long-term ALPMY plot

Financial data

YTD 2022-03-31 2023-03-31 2024-03-31
Operating Revenue ¥1,296,163.00MM ¥1,518,619.00MM ¥1,603,672.00MM
Operating Expenses ¥1,140,477.00MM ¥1,233,189.00MM ¥1,578,154.00MM
Operating Income ¥155,686.00MM ¥285,430.00MM ¥25,518.00MM
Non-Operating Income ¥711.00MM ¥-153,069.00MM ¥-549.00MM
Interest Expense ¥4,949.00MM ¥8,779.00MM ¥12,005.00MM
R&D Expense ¥246,010.00MM ¥276,128.00MM ¥294,200.00MM
Income(Loss) ¥156,397.00MM ¥132,361.00MM ¥24,969.00MM
Taxes ¥32,800.00MM ¥33,647.00MM ¥7,924.00MM
Profit(Loss)* ¥124,086.00MM ¥98,714.00MM ¥17,045.00MM
Stockholders Equity ¥1,460,308.00MM ¥1,507,954.00MM ¥1,595,988.00MM
Inventory ¥153,072.00MM ¥174,386.00MM ¥248,738.00MM
Assets ¥2,332,394.00MM ¥2,456,518.00MM ¥3,569,603.00MM
Operating Cash Flow ¥258,160.00MM ¥332,325.00MM ¥172,475.00MM
Capital expenditure ¥76,448.00MM ¥88,541.00MM ¥82,497.00MM
Investing Cash Flow ¥-63,129.00MM ¥-89,058.00MM ¥-845,802.00MM
Financing Cash Flow ¥-216,298.00MM ¥-195,623.00MM ¥614,060.00MM
Earnings Per Share** ¥67.08 ¥54.24 ¥9.51
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.